Patrick Lavery on Muck Rack

Patrick Lavery

Verified
United States
As seen in: Contract Pharma, JD Supra, NewsBreak, WKXW-FM (Ewing, NJ), The National Law Review, Mondaq, MJH Life Sciences, Climate Depot, Pharmaceutical Executive, NewsBeezer, Pharmaceutical Technology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Patrick

Contact Patrick, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Unlocking Secondary Packaging’s Potential to Accelerate Smart Tech Adoption and Sustainability Goals

|
By Patrick Lavery Verified
| Contract Pharma Verified
Secondary packaging, which gives additional physical protection to a proximity package, is increasingly a darling of companies’ smart technologies and sustainability goals. Up to now, it had received less attention in those areas than primary packaging, its closer cousin in relation to a drug product. Yet as companies with packaging interests set short- and long-term sustainability goals, they are finding secondary packaging provides a wide pathway to those objectives.
Open in Who Shared Issue with article?

Best Practices for Tech Transfers Amid a Revolution in Digitalization

|
By Patrick Lavery Verified
| Contract Pharma Verified
For contract development and manufacturing organizations (CDMOs) that partner with companies on a technology transfer, the process may be familiar but nevertheless daunting. And while electronic records management in some form has been a long-accepted element of this process, the explosion of artificial intelligence (AI) platforms in the last three years has added both the potential for new and game-changing efficiencies as well as crippling pitfalls.
Open in Who Shared Issue with article?

Improving Cell and Gene Therapy Scale-Up with a Digital-First Approach

|
By Patrick Lavery Verified
| Contract Pharma Verified
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to another. A few years ago, irrational exuberance set sky-high expectations; more recently, pessimism has taken hold. The reality is steadier progress, less flashy, but laying the groundwork for lasting patient impact. And while investor sentiment may fluctuate, big pharma continues to make promising moves in the space.
Open in Who Shared Issue with article?
See all 4,013 licensed articles (4,576 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified